论文部分内容阅读
目前 ,肿瘤的基因治疗研究正迅速地由实验室走向临床[1] ,研究的热点之一是制备高效、导向性的基因导入系统。本研究观察了一种新的以表皮生长因子受体 (ＥＧＦＲ)为靶向的 16肽的真核表达基因导入系统(ＧＥ7系统 ) [2 ] 与细胞周期素依赖的蛋白激酶抑制物(ＣＫＩ)基因ｐ2 1相
At present, tumor gene therapy research is rapidly moving from the laboratory to the clinic [1]. One of the research hotspots is the preparation of an efficient and directional gene introduction system. In this study, a new eukaryotic expression gene transfer system (GE7 system) [16] and cyclin-dependent protein kinase inhibitor (CKI) targeting the epidermal growth factor receptor (EGFR)-targeted 16 peptide was observed. Gene p2 1 phase